<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2008-12-4-36-44</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>ОПЫТ ПРИМЕНЕНИЯ ПРЕДИЛЮЦИОННОЙ ОН-ЛАЙН ГЕМОДИАФИЛЬТРАЦИИ У БОЛЬНЫХ С ТЕРМИНАЛЬНОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ</article-title><trans-title-group xml:lang="en"><trans-title>THE EXPERIENCE OF USE OF PREDILUTIONARY ON-LINE HEMODIAFILTRATION IN PATIENTS WITH END STAGE RENAL DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильев</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasiliev</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра нефрологии и диализа</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Губарь</surname><given-names>Н. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Gubar</surname><given-names>N. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра пропедевтики внутренних болезней</p><p>197089, Санкт-Петербург, ул. Л.Толстого, 17. Тел.: (812)234-57-36</p></bio><email xlink:type="simple">ngubar@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кафедра пропедевтики внутренних болезней, Научно-исследовательский институт нефрологии </p><p> </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Суглобова</surname><given-names>Е. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Suglobova</surname><given-names>E. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский институт нефрологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>10</day><month>04</month><year>2008</year></pub-date><volume>12</volume><issue>4</issue><fpage>36</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Васильев А.Н., Губарь Н.Я., Смирнов А.В., Суглобова Е.Д., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Васильев А.Н., Губарь Н.Я., Смирнов А.В., Суглобова Е.Д.</copyright-holder><copyright-holder xml:lang="en">Vasiliev A.N., Gubar N.Y., Smirnov A.V., Suglobova E.D.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1130">https://journal.nephrolog.ru/jour/article/view/1130</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ:на основании изучения динамики клинико-лабораторных показателей дать комплексную оценку эффективности применения предилюционной гемодиафильтрации при TПН. ПАЦИЕНТЫ И МЕТОДЫ. Общее количество обследованных пациентов составило 86 человек. При рандомизации выборки, были выделены 46 пациентов, которые были разделены на две группы: основной группе (25 пациентов) вместо процедуры гемодиализа проводилась предилюционная он-лайн гемодиафильтрация в среднем 12,5 часов в неделю. Контрольная группа (21 пациент) получала хронический гемодиализ той же продолжительности. Наблюдение за пациентами основной (ГДФ) и контрольной группы (ГД) проводилось в течение 1,5 мес. – 6 недель – 20 сеансов ЗПТ. Наиболее частой причиной развития терминальной ХПН, у больных основной группы был хронический гломерулонефрит (74%), хронический пиелонефрит (4%), поликистоз почек (8%), сахарный диабет (4%), системный васкулит (8%); у пациентов контрольной группы - хронический гломерулонефрит (71%), хронический пиелонефрит (14%), поликистоз почек (10%), сахарный диабет (6%). РЕЗУЛЬТАТЫ. Показано положительное воздействие предилюционной он-лайн гемодиафильтрации на показатели гемодинамической стабильности и дозы диализа (p&lt;0,001), фиксировался рост ЛПВП (p&lt;0.004), выявлено снижения уровня общего гомоцистеина (p&lt;0.001) и С-реактивного белка (p&lt;0,002). Отмечалось достоверное снижении додиализного уровня фосфата (p&lt;0,015), и паратиреодиного гормона (p&lt;0.003), а также значимый рост показателей красной крови. Выявлено снижение уровня общего белка и альбумина плазмы у пациентов, получавших терапию ГДФ (p&lt;0.005). ЗАКЛЮЧЕНИЕ. Применение предилюционной он-лайн гемодиафильтрации в течение 1.5 месяцев оказывает комплексное положительное влияние на большинство показателей обмена веществ у пациентов с терминальной почечной недостаточностью.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the investigation: on the basis of the investigation of the dynamics of clinical and laboratory data to give a complex evaluation of the effectiveness of predilutionary hemofiltration in ESRD. PATIENTS AND METHODS. The total number of investigated patients was 86. After randomization, 46 patients were picked, and divided into two groups: main group (25 patients) instead of hemodyalisis procedure had an predilutionary on-line hemofiltration of the mean of 12,5 hours per week. The control group (21 patient) had chronic hemodyalisis of the same duration. The observation on the main (HDF) and control (CG) groups was made during 1,5 month – 6 weeks – 20 sessions of RRT. The most often cause for the development of the terminal stage of HRF, in the main group patients with was chronic glomerulonephritis (74%), chronic pielonephritis (4%), renal polycystosis (8%), diabetes (4%), system vasculitis (8%); in the control group patients – glomerulonephritis (71%), chronic pielonephritis (14%), renal polycystosis (10%), diabetes (6%). RESULTS. The positive effect of predilutionary on-line hemofiltration on the data that characterizes the hemodynamic stability and dialysis doze (p&lt;0,001), the increase of LPLD was noted (p&lt;0,004), also was noted the decrease in the level of total homocystein (p&lt;0,001) and C-reactive protein (p&lt;0,002). The reliable decrease in the dilatational level of phosphate (p&lt;0,0015) and parathyroid hormone (p&lt;0,003) was noted, and also a valuable increase in the red blood values. A decrease of the total protein level and plasma albumin in patients receiving HDF therapy was observed. CONCLUSION. The use of predilutionary on-line hemofiltration during the 1,5 month has a complex positive effect on the majority of the values of the substance exchange in the patients with terminal renal failure.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Гемодиафильтрация</kwd><kwd>гемодиализ</kwd><kwd>конвекция</kwd><kwd>терминальная почечная недостаточность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hemofiltration</kwd><kwd>hemodyalisis</kwd><kwd>convection</kwd><kwd>end stage renal disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15 (5): 458-482</mixed-citation><mixed-citation xml:lang="en">Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15 (5): 458-482</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Phelan P, O’Kelly P, Walshe J et al. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients. Ren Fail2008; 30 (4): 423-429</mixed-citation><mixed-citation xml:lang="en">Phelan P, O’Kelly P, Walshe J et al. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients. Ren Fail2008; 30 (4): 423-429</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz D, de Cal M, Ronco C. Oxidative stress and anemia in chronic hemodialysis: the promise of bioreactive membranes. Contrib Nephrol 2008; 161: 89-98</mixed-citation><mixed-citation xml:lang="en">Cruz D, de Cal M, Ronco C. Oxidative stress and anemia in chronic hemodialysis: the promise of bioreactive membranes. Contrib Nephrol 2008; 161: 89-98</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ostermann M. Cardiac arrests in hemodialysis patients: An ongoing challenge. Kidney Int 2008; 73 (4): 907-908</mixed-citation><mixed-citation xml:lang="en">Ostermann M. Cardiac arrests in hemodialysis patients: An ongoing challenge. Kidney Int 2008; 73 (4): 907-908</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Barri Y. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 2008; 10 (1): 39-45</mixed-citation><mixed-citation xml:lang="en">Barri Y. Hypertension and kidney disease: a deadly connection. Curr Hypertens Rep 2008; 10 (1): 39-45</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">London G, Marchais S, Guerin A et al. Arterial hypertension, chronic renal insufficiency and dialysis. Nephrol Ther 2007; 3 [Suppl 3]: S156-161</mixed-citation><mixed-citation xml:lang="en">London G, Marchais S, Guerin A et al. Arterial hypertension, chronic renal insufficiency and dialysis. Nephrol Ther 2007; 3 [Suppl 3]: S156-161</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Culleton BF, Wilson PW. Cardiovascular disease: risk factors, secular trends, and therapeutic guidelines. J Am Soc Nephrol 1998; 9 [Suppl 12]: S5-S15</mixed-citation><mixed-citation xml:lang="en">Culleton BF, Wilson PW. Cardiovascular disease: risk factors, secular trends, and therapeutic guidelines. J Am Soc Nephrol 1998; 9 [Suppl 12]: S5-S15</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kunz K, Petitjean P, Lisri M et al. Cardiovascular morbidity and endothelial dysfunction in chronic HD patients: is homocysteine the missing link? Nephrol Dial Transpl 1999; 14 (8): 1934-1942</mixed-citation><mixed-citation xml:lang="en">Kunz K, Petitjean P, Lisri M et al. Cardiovascular morbidity and endothelial dysfunction in chronic HD patients: is homocysteine the missing link? Nephrol Dial Transpl 1999; 14 (8): 1934-1942</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bostom A.G, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52 (1): 10-20</mixed-citation><mixed-citation xml:lang="en">Bostom A.G, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52 (1): 10-20</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Chauveau P, Chadefaux B, Coude M et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993; 43 [Suppl 41]: 72-77</mixed-citation><mixed-citation xml:lang="en">Chauveau P, Chadefaux B, Coude M et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993; 43 [Suppl 41]: 72-77</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Haas T, Hillton D, Dongardy G. Phosphate kinetics in dialysis patients. Nephrol Dial Transpl 1991; 6 [Suppl 2]: 108-113</mixed-citation><mixed-citation xml:lang="en">Haas T, Hillton D, Dongardy G. Phosphate kinetics in dialysis patients. Nephrol Dial Transpl 1991; 6 [Suppl 2]: 108-113</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">McCarley PB, Arjomand M. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. Nephrol Nurs J 2008; 35 (1): 59-64</mixed-citation><mixed-citation xml:lang="en">McCarley PB, Arjomand M. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences. Nephrol Nurs J 2008; 35 (1): 59-64</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Akgul A, Bilgic A, Sezer S et al. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients. J Ren Nutr 2008; 18 (4): 338-346</mixed-citation><mixed-citation xml:lang="en">Akgul A, Bilgic A, Sezer S et al. Low total plasma homocysteine level in relation to malnutrition, inflammation, and outcome in hemodialysis patients. J Ren Nutr 2008; 18 (4): 338-346</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J 1975; 51 (597): 450-452</mixed-citation><mixed-citation xml:lang="en">Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J 1975; 51 (597): 450-452</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Eckard KU. Anaemia correction – does the mode of dialysis matter. Nephrol Dial Transpl 2000; 15(9): 1278-1280</mixed-citation><mixed-citation xml:lang="en">Eckard KU. Anaemia correction – does the mode of dialysis matter. Nephrol Dial Transpl 2000; 15(9): 1278-1280</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chanard J, Brunois IP, Melin JP et al. Long-term result of dialysis therapy with a highly permeable membrane. Artif Organs 1982; 6 (3): 261-266</mixed-citation><mixed-citation xml:lang="en">Chanard J, Brunois IP, Melin JP et al. Long-term result of dialysis therapy with a highly permeable membrane. Artif Organs 1982; 6 (3): 261-266</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Leypoldt JK, Schmidt B, Gurland HJ. Net ultrafiltration may not eliminate backfiltration during hemodialysis with highly permeable membranes. Artif Organs 1991; 15 (3): 164-170</mixed-citation><mixed-citation xml:lang="en">Leypoldt JK, Schmidt B, Gurland HJ. Net ultrafiltration may not eliminate backfiltration during hemodialysis with highly permeable membranes. Artif Organs 1991; 15 (3): 164-170</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Henderson LW. The beginning of Hemofiltration. Contribution to Nephrology 1982; 32: 1-20</mixed-citation><mixed-citation xml:lang="en">Henderson LW. The beginning of Hemofiltration. Contribution to Nephrology 1982; 32: 1-20</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lysaght MJ. The History of Hemofiltration. Hemofiltration. Springer-Verlag, 1986; 1-17</mixed-citation><mixed-citation xml:lang="en">Lysaght MJ. The History of Hemofiltration. Hemofiltration. Springer-Verlag, 1986; 1-17</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Canaud B, Bosc JY, Leray-Moragues H et al. On-line hemodiafiltration. Safety and effcacy in long-term clinical practice. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 60-67</mixed-citation><mixed-citation xml:lang="en">Canaud B, Bosc JY, Leray-Moragues H et al. On-line hemodiafiltration. Safety and effcacy in long-term clinical practice. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 60-67</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Жлоба АА, Блашко ЭЛ. Определение общего гомоцистеина в плазме крови методом обращеннофазной жидкостной хроматографии с использованием колонок С 8 и С 18. Уч записки СПбГМУ им акад И. П. Павлова 2004; 11 (2): 20-25</mixed-citation><mixed-citation xml:lang="en">Жлоба АА, Блашко ЭЛ. Определение общего гомоцистеина в плазме крови методом обращеннофазной жидкостной хроматографии с использованием колонок С 8 и С 18. Уч записки СПбГМУ им акад И. П. Павлова 2004; 11 (2): 20-25</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ware JE, Snow KK, Kosinski M et al. SF"36 Health Survey. Manual and interpretation guide.The Health Institute, New England Medical Center. Boston, 1993; 19-22</mixed-citation><mixed-citation xml:lang="en">Ware JE, Snow KK, Kosinski M et al. SF"36 Health Survey. Manual and interpretation guide.The Health Institute, New England Medical Center. Boston, 1993; 19-22</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rahman M, Fu P, Sehgal AR et al. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35 (2): 257-265</mixed-citation><mixed-citation xml:lang="en">Rahman M, Fu P, Sehgal AR et al. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35 (2): 257-265</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Rocco MV, Yan G, Heyka RJ et al. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001; 21 (4): 280-288</mixed-citation><mixed-citation xml:lang="en">Rocco MV, Yan G, Heyka RJ et al. Risk factors for hypertension in chronic hemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001; 21 (4): 280-288</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Рыков ВГ, Суглобова ЕД. Артериальная гипертензия, как фактор риска повышенной летальности у больных, получающих лечение методом хронического гемодиализа, и подходы к ее коррекции. Нефрология 2003; 7 (3): 7-13</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Рыков ВГ, Суглобова ЕД. Артериальная гипертензия, как фактор риска повышенной летальности у больных, получающих лечение методом хронического гемодиализа, и подходы к ее коррекции. Нефрология 2003; 7 (3): 7-13</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kooman J, Basci A, Pizzarelli F et al. EBPG guideline on hemodynamic instability. Nephrol Dial Transplant 2007; 22 [Suppl 2]: ii22-44</mixed-citation><mixed-citation xml:lang="en">Kooman J, Basci A, Pizzarelli F et al. EBPG guideline on hemodynamic instability. Nephrol Dial Transplant 2007; 22 [Suppl 2]: ii22-44</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Donauer J, Schweiger C, Rumberger B et al. Reduction of hypotensive side effects during online-hemodiafiltration and low temperature hemodialysis. Nephrol Dial Transplant 2003; 18 (6): 1616-1622</mixed-citation><mixed-citation xml:lang="en">Donauer J, Schweiger C, Rumberger B et al. Reduction of hypotensive side effects during online-hemodiafiltration and low temperature hemodialysis. Nephrol Dial Transplant 2003; 18 (6): 1616-1622</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Santoro A, Mancini E, Canova C et al. Thermal balance in convective therapies. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii41-vii45</mixed-citation><mixed-citation xml:lang="en">Santoro A, Mancini E, Canova C et al. Thermal balance in convective therapies. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii41-vii45</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Butkevich A, Phillips RA, Sheinart KF et al. The effects of various definitions of dipping and daytime and night-time on characterization of 24h profiles of blood pressure. Blood Press. Monit 2000; 5: 19-22</mixed-citation><mixed-citation xml:lang="en">Butkevich A, Phillips RA, Sheinart KF et al. The effects of various definitions of dipping and daytime and night-time on characterization of 24h profiles of blood pressure. Blood Press. Monit 2000; 5: 19-22</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ahlman J. Quality of life of the dialysis patient in Replacement of renal function by dialysis. In: Jacobs C, Kjellstrand CM, Koch KM, eds. Kluwer, Dordecht/Boston/London, 1996: 460-477</mixed-citation><mixed-citation xml:lang="en">Ahlman J. Quality of life of the dialysis patient in Replacement of renal function by dialysis. In: Jacobs C, Kjellstrand CM, Koch KM, eds. Kluwer, Dordecht/Boston/London, 1996: 460-477</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Щербак ИГ. Биологическая химия.Изд-во СПбГМУ, СПб, 2005: 350-369</mixed-citation><mixed-citation xml:lang="en">Щербак ИГ. Биологическая химия.Изд-во СПбГМУ, СПб, 2005: 350-369</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Basile C. The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii46-vii49</mixed-citation><mixed-citation xml:lang="en">Basile C. The effect of convection on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 2003; 18 [Suppl 7]: vii46-vii49</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Desmeules S, Levesque R, Jaussent I et al. Creatinine index and lean body mass are excellent predictors of long-term survival in hemodiafiltration patients. Nephrol Dial Transplant 2004; 19 (5): 1182-1189</mixed-citation><mixed-citation xml:lang="en">Desmeules S, Levesque R, Jaussent I et al. Creatinine index and lean body mass are excellent predictors of long-term survival in hemodiafiltration patients. Nephrol Dial Transplant 2004; 19 (5): 1182-1189</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Kaysen GA. Role of inflammation and its treatment in ESRD patients. Blood Purif 2002; 20 (1): 70-80</mixed-citation><mixed-citation xml:lang="en">Kaysen GA. Role of inflammation and its treatment in ESRD patients. Blood Purif 2002; 20 (1): 70-80</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Назаров ПГ. Реактанты острой фазы воспаления. Наука, СПб., 2001; 125-133</mixed-citation><mixed-citation xml:lang="en">Назаров ПГ. Реактанты острой фазы воспаления. Наука, СПб., 2001; 125-133</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Cotter D, Zhang Y, Thamer M et al. The effect of epoetin dose on hematocrit. Kidney Int 2008; 73 (3): 347-53</mixed-citation><mixed-citation xml:lang="en">Cotter D, Zhang Y, Thamer M et al. The effect of epoetin dose on hematocrit. Kidney Int 2008; 73 (3): 347-53</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Macdougall IC, Padhi D, Jang G. Pharmacology of darbepoetin alfa. Nephrol Dial Transplant 2007; 22 [Suppl 4]: iv2-iv9</mixed-citation><mixed-citation xml:lang="en">Macdougall IC, Padhi D, Jang G. Pharmacology of darbepoetin alfa. Nephrol Dial Transplant 2007; 22 [Suppl 4]: iv2-iv9</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ермоленко ВМ, Иващенко МА. Уремия и эритропоэтин. Медицина, М., 1999; 86-89</mixed-citation><mixed-citation xml:lang="en">Ермоленко ВМ, Иващенко МА. Уремия и эритропоэтин. Медицина, М., 1999; 86-89</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Константинов ЮВ, Гуревич КЯ, Абдурахимов СМ. Оценка адекватности хронического диализа. Санкт-Петербург, 1999. 1-29</mixed-citation><mixed-citation xml:lang="en">Константинов ЮВ, Гуревич КЯ, Абдурахимов СМ. Оценка адекватности хронического диализа. Санкт-Петербург, 1999. 1-29</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Pertosa G, Grandaliano G, Gesualdo L et al. Clinical relevance of cytokines production in hemodialysis. Kidney Int 2000; 58 [Suppl 76]: S104-111</mixed-citation><mixed-citation xml:lang="en">Pertosa G, Grandaliano G, Gesualdo L et al. Clinical relevance of cytokines production in hemodialysis. Kidney Int 2000; 58 [Suppl 76]: S104-111</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Lin CL, Huang CC, Yu CC et al. Improved iron utilization and reduced erythropoetin resistance by on-line hemodiafiltration. Blood Purif 2002; 20 (4): 349-356</mixed-citation><mixed-citation xml:lang="en">Lin CL, Huang CC, Yu CC et al. Improved iron utilization and reduced erythropoetin resistance by on-line hemodiafiltration. Blood Purif 2002; 20 (4): 349-356</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1555</mixed-citation><mixed-citation xml:lang="en">Kaysen GA. The microinflammatory state in uremia: Causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1555</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Meytes D, Bodin E, Ma A et al. Effect of parathyreoid hormone on erythropoesis. J Clin Invest 1981; 67: 1263-1269</mixed-citation><mixed-citation xml:lang="en">Meytes D, Bodin E, Ma A et al. Effect of parathyreoid hormone on erythropoesis. J Clin Invest 1981; 67: 1263-1269</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium-phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis1998; 31 (4): 607-617</mixed-citation><mixed-citation xml:lang="en">Block GA, Hulbert-Shearon TE, Levin NW et al. Association of serum phosphorus and calcium-phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis1998; 31 (4): 607-617</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
